A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure
复制标题
DOI:
10.1056/nejmoa1610426
复制
发表时间:
2017-02-02
影响因子:
158.5
通讯作者:
Salerno, Christopher
中科院分区:
文献类型:
--
作者:
Mehra, Mandeep R.;Naka, Yoshifumi;Salerno, Christopher
BACKGROUNDContinuous-flow left ventricular assist systems increase the rate of survival among patients with advanced heart failure but are associated with the development of pump thrombosis. We investigated the effects of a new magnetically levitated centrifugal continuous-flow pump that was engineered to avert thrombosis.METHODSWe randomly assigned patients with advanced heart failure to receive either the new centrifugal continuous-flow pump or a commercially available axial continuous-flow pump. Patients could be enrolled irrespective of the intended goal of pump support (bridge to transplantation or destination therapy). The primary end point was a composite of survival free of disabling stroke (with disabling stroke indicated by a modified Rankin score >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove the device at 6 months after implantation. The trial was powered for noninferiority testing of the primary end point (noninferiority margin, -10 percentage points).RESULTSOf 294 patients, 152 were assigned to the centrifugal-flow pump group and 142 to the axial-flow pump group. In the intention-to-treat population, the primary end point occurred in 131 patients (86.2%) in the centrifugal-flow pump group and in 109 (76.8%) in the axial-flow pump group (absolute difference, 9.4 percentage points; 95% lower confidence boundary, -2.1 [P